Josh Waizer

Josh Waizer is an expert in healthcare and antitrust issues. He has more than a decade of experience providing economic analysis to clients including health plans, providers, pharmaceutical manufacturers, and government agencies. He has expertise in analyzing health insurance, provider competition, and reimbursement issues, including analyzing large healthcare claims data sets and other types of data. Mr. Waizer has led or contributed to a variety of matters involving mergers, monopolization and monopsonization, class certification, damages assessments, pricing and reimbursements, health plan networks, contract disputes, big tech, advertising, and intellectual property.

BA, Economics (with honors), Brandeis University

BA, Politics, Brandeis University

• Submitted an expert report to a state agency assessing insurer market shares and concentration.
• Co-authored a submission to a state agency assessing the competitive impact of a contract between a health plan and a hospital system.
• In In re National Prescription Opiate Litigation and in related litigation concerning allegations of inappropriate marketing of prescription opioids, served as consulting expert and led the team supporting testifying experts on behalf of Allergan on issues of causation and damages.
• In Ronald Emilio Reyna v. Celtic Insurance Company, served as a consulting expert and led the team supporting the testifying expert on behalf of Celtic, addressing the economics of healthcare prices and the determination of usual, customary, and reasonable (UCR) rates.
• On behalf of Emory Healthcare, led the team supporting the expert in analyzing potential competitive effects of Emory’s proposed acquisition of DeKalb Medical Center.
• In United States v. Google, LLC, a civil antitrust lawsuit alleging that Google unlawfully monopolized or attempted to monopolize markets involving digital advertising technologies, provided expert support on behalf of the Department of Justice (DOJ) addressing market definition, market power, and competitive effects.
• In Epic Games Inc. v. Google LLC et al., a case concerning the monopolization of app distribution on Android smartphones, provided expert support on behalf of Epic addressing market definition, market power, theory of harm, and competitive effects.
• In In re LIBOR-Based Financial Instruments Antitrust Litigation—The OTC Action, provided expert support on behalf of a class of over-the-counter plaintiffs in a lawsuit against the global banks that set US Dollar LIBOR.
• On behalf of Steward Health Care in Steward Health Care System LLC et al. v. Blue Cross & Blue Shield of Rhode Island, co-led the team supporting the testifying expert and provided consulting expertise on behalf of Steward.
• Supported the expert on behalf of the Federal Trade Commission in its proceedings seeking to block Cabell Huntington Hospital’s acquisition of St. Mary’s Medical Center in Huntington, WV.
• In In re WellPoint, Inc. Out-of-Network “UCR” Rates Litigation, provided expert support on economic issues associated with class certification and merits on behalf of defendant WellPoint in connection with alleged underpayment of out-of-network benefits associated with alleged violations of ERISA, California UCL, breach of warranty, and breach of implied covenant of good faith obligations. 
• On behalf of Humana in connection with its proposed merger with Aetna, provided support for responses to the Department of Justice's second request and analyzed likely competitive effects in the sale of Medicare Advantage products.